Theradaptive: Funding, Investors & Team (Oct 2026)
Theradaptive is a clinical-stage biologics company that is privately held and focused on developing protein therapeutics for spine, orthopedics, soft tissue repair, and targeted immuno-oncology. The company's innovative platform converts recombinant proteins into material-binding variants that can be used to coat implants, devices, and injectable carriers for various medical treatments. Theradaptive's lead candidate, OsteoAdapt SP™, is currently being evaluated in a Phase I/II clinical trial for degenerative disc disease, a condition that causes spinal joint deterioration and pain. This candidate combines Theradaptive's engineered protein AMP2™ with a synthetic bone graft to address this challenging medical issue.
Theradaptive has raised $63.2M across 6 funding rounds on record, the most recent an undisclosed round of $36.2M announced in Aug 2026.
That round is above the $4.9M median round size for Health Care companies tracked on FundedIQ over the last two years.
Theradaptive Company Profile and Key Stats
Latest funding round on record: Aug 2026.
Theradaptive Funding Rounds
3 of 6 rounds were announced without a disclosed amount and are excluded from the total.
Theradaptive raised $26.0M in a Series A announced in Jun 2023.
11 months later, an undisclosed round of $1.0M was announced in May 2024.
1.3 years later, an undisclosed round was announced in Aug 2025 with no disclosed amount.
2 months later, an undisclosed round was announced in Oct 2025 with no disclosed amount.
7 months later, an undisclosed round was announced in May 2026 with no disclosed amount.
3 months later, an undisclosed round of $36.2M was announced in Aug 2026.
Theradaptive Investors
Theradaptive Founders and Leadership Team
Contact details for the Theradaptive team: 3 of 3 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Theradaptive Funding Compared to Other Health Care Startups
Theradaptive's latest round of $36.2M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Theradaptive in Health Care and Frederick
Companies Similar to Theradaptive
Using technology and the best professionals, Wally, a membership-based dental care service, offers proactive,…
PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by…
General Medicine provides a convenient and straightforward way to access top-quality healthcare services with…
Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign…
SedMed provides medical devices that support safer toileting transfers and help prevent falls for individuals…
Aptatek is developing cutting edge technologies for portable disease management devices that will improve…
Flow Medical offers multi-function catheters to aid in the diagnosis and treatment of venous thromboembolic…
Light Wave Dental Management offers management services for high-quality dental offices in Virginia.…
For health care systems and payers focused on improving maternal outcomes and health equity, our product is a…
Tempo Therapeutics creates materials that are designed for regenerative medicine, with a focus on being…
Vibronix was established by Dr. Ji-Xin Cheng and Dr. Pu Wang at Purdue University with the goal of offering…
People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…
Theradaptive Funding FAQs
What does Theradaptive do?
Theradaptive is a clinical-stage biologics company that is privately held and focused on developing protein therapeutics for spine, orthopedics, soft tissue repair, and targeted immuno-oncology. The company's innovative platform converts recombinant proteins into material-binding variants that can be used to coat implants, devices, and injectable carriers for various medical treatments. Theradaptive's lead candidate, OsteoAdapt SP™, is currently being evaluated in a Phase I/II clinical trial for degenerative disc disease, a condition that causes spinal joint deterioration and pain. This candidate combines Theradaptive's engineered protein AMP2™ with a synthetic bone graft to address this challenging medical issue.
How much funding has Theradaptive raised?
Theradaptive has raised $63.2M across 6 rounds on record. The most recent is an undisclosed round of $36.2M announced in Aug 2026.
When did Theradaptive last raise funding?
Theradaptive's most recent funding round on record is an undisclosed round of $36.2M, announced in Aug 2026.
Who has invested in Theradaptive?
Investors on record for Theradaptive include U.S. Department of War, Maryland Department of Commerce, Maryland Stem Cell Research Fund (MSCRF).
Who founded Theradaptive?
FundedIQ lists Anita Gugel (Founder), Luis Alvarez (Founder) at Theradaptive.
Where is Theradaptive headquartered?
Theradaptive is based in Frederick, Maryland, United States.
How many employees does Theradaptive have?
Theradaptive is in the 11-50 employee band.
When was Theradaptive founded?
Theradaptive was founded in 2016.
How does Theradaptive's funding compare to other Health Care startups?
Theradaptive's latest round of $36.2M is above the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.
About FundedIQ's Theradaptive Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Theradaptive is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.